Atlas Trials

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

Clinical trial NCT00834327 · TERMINATED

Trial details

NCT number
NCT00834327
Sponsor
Neurogen Corporation
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Restless Legs Syndrome
Start date
2009-02-01
Primary completion
2009-11-01
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.